TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19485840

Group type: EXPERIMENTAL
Intervention: Point-of-care testing (PoCT)
Number of subjects: 4968

Group type: COMPARATOR
Intervention: Pathology laboratory testing
Number of subjects: 4968
Study: 17595593

Group type: EXPERIMENTAL
Intervention: Low-dose transdermal estradiol (E2)/norethisterone acetate (NETA) patches (Estalis 25/125)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose oral E2/NETA (Activelle)
Number of subjects: 0
Study: 15168217

Group type: EXPERIMENTAL
Intervention: 200 mg modafinil
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 11435839

Group type: EXPERIMENTAL
Intervention: Prelubricated nonhydrophilic catheter
Number of subjects: 18

Group type: COMPARATOR
Intervention: Nélaton catheter
Number of subjects: 18
Study: 9544873

Group type: EXPERIMENTAL
Intervention: 4 mg of trandolapril
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: 240 mg of verapamil SR
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: Combination of 4 mg of trandolapril and 240 mg of verapamil SR
Number of subjects: 631

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 631
Study: 8291491

Group type: EXPERIMENTAL
Intervention: 0.4% stannous fluoride gel (SnF2) used twice daily for 18 months
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard fluoride toothpaste with toothbrushing (control)
Number of subjects: 62
Study: 2566736

Group type: EXPERIMENTAL
Intervention: Adrenaline plus polidocanol 1%
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Adrenaline plus YAG laser therapy
Number of subjects: 140

Group type: COMPARATOR
Intervention: Adrenaline alone
Number of subjects: 140

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 140
Study: 30678679

Group type: EXPERIMENTAL
Intervention: Outpatient psychiatric treatment for clinical mental disorder
Number of subjects: 586

Group type: EXPERIMENTAL
Intervention: Preventive cognitive behavioural therapy for subclinical conditions
Number of subjects: 586

Group type: COMPARATOR
Intervention: Composed control group
Number of subjects: 586
Study: 27966239

Group type: EXPERIMENTAL
Intervention: ICD codes
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: DRG codes
Number of subjects: 427
Study: 25852125

Group type: EXPERIMENTAL
Intervention: lamivudine (LAM, n=82)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: tenofovir/emtricitabine (TDF/FTC, n=86)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: lamivudine (LAM)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: tenofovir/emtricitabine (TDF/FTC)
Number of subjects: 168
Study: 23866798

Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass grafting
Number of subjects: 280

Group type: COMPARATOR
Intervention: Percutaneous coronary intervention
Number of subjects: 280
Study: 21826713

Group type: EXPERIMENTAL
Intervention: On-demand neuromodulation
Number of subjects: 16

Group type: COMPARATOR
Intervention: Continuous neuromodulation (Control)
Number of subjects: 16
Study: 19687086

Group type: EXPERIMENTAL
Intervention: Modified carpal tunnel syndrome questionnaire (Boston Carpal Tunnel Questionnaire, BCTQ)
Number of subjects: 76
Study: 17644487

Group type: EXPERIMENTAL
Intervention: Cranio-cervical flexion (CCF) exercise
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Cervical flexion (CF) exercise
Number of subjects: 48
Study: 15325681

Group type: EXPERIMENTAL
Intervention: Glutamine (Gln) supplementation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo amino acid
Number of subjects: 20
Study: 11159567

Group type: EXPERIMENTAL
Intervention: Electrodermal testing using the Vegatest device
Number of subjects: 30
Study: 9674373

Group type: EXPERIMENTAL
Intervention: Partially operational ATM mock-up with natural speech output, different function menus, and different key arrangements
Number of subjects: 15

Group type: COMPARATOR
Intervention: Partially operational ATM mock-up
Number of subjects: 15
Study: 7493120

Group type: EXPERIMENTAL
Intervention: Transsclerally fixed anterior chamber lenses with S-shaped haptics and multipoint support
Number of subjects: 0

Group type: COMPARATOR
Intervention: C-loop posterior chamber lens
Number of subjects: 0
Study: 2692227

Group type: EXPERIMENTAL
Intervention: Maloprim (pyrimethamine + dapsone)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chlorproguanil (Lapudrine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 0
Study: 4653876

Group type: EXPERIMENTAL
Intervention: Modified water recovery test
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fluoroscopy
Number of subjects: 50
Study: 31789201

Group type: EXPERIMENTAL
Intervention: Weekend work (nonstandard schedules) for mothers
Number of subjects: 21766

Group type: EXPERIMENTAL
Intervention: Nonstandard hours for women without children
Number of subjects: 21766

Group type: EXPERIMENTAL
Intervention: Maternal nonstandard hour work
Number of subjects: 21766

Group type: EXPERIMENTAL
Intervention: Nonstandard days and hours for men without children
Number of subjects: 21766
Study: 30925499

Group type: EXPERIMENTAL
Intervention: Paliperidone ER
Number of subjects: 106

Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 106
Study: 28539646

Group type: EXPERIMENTAL
Intervention: High Acetate (HA)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High Propionate (HP)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High Butyrate (HB)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study: 23971514

Group type: EXPERIMENTAL
Intervention: Tailored advice regarding exposure to daylight, optimizing sleep, physical activity, and nutrition delivered via a smartphone application and website.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard available information (Control group).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tailored advice regarding exposure to daylight, optimizing sleep, physical activity, and nutrition.
Number of subjects: 0
Study: 21299387

Group type: EXPERIMENTAL
Intervention: Rapid maxillary expansion and cervical pull headgear (RME/HG)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Cervical pull headgear (HG)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Untreated control group (CG)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 64
Study: 19938903

Group type: EXPERIMENTAL
Intervention: Vernakalant hydrochloride
Number of subjects: 0
Study: 16715781

Group type: EXPERIMENTAL
Intervention: Fluoxetine tablets (test)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fluoxetine capsules (reference)
Number of subjects: 24
Study: 14982197

Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Angiotensin-converting enzyme (ACE) inhibitors
Number of subjects: 0
Study: 11753061

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia with bupivacaine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia with lidocaine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: General anesthesia
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Femoral nerve block of injured leg only
Number of subjects: 15

Group type: COMPARATOR
Intervention: Overall (all groups)
Number of subjects: 15
Study: 9252131

Group type: EXPERIMENTAL
Intervention: Loperamide (8 mg, ingested 13 and 4 hours before the meal)
Number of subjects: 8
Study: 8375421

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 50 mg twice daily
Number of subjects: 461

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 461
Study: 3752983

Group type: EXPERIMENTAL
Intervention: Aztreonam (2 g intravenously every 6 hours for 21 doses)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline placebo (control group)
Number of subjects: 10
Study: 31881985

Group type: EXPERIMENTAL
Intervention: Lebanese Insomnia Scale (LIS-18)
Number of subjects: 789
Study: 29707866

Group type: EXPERIMENTAL
Intervention: Dorzagliatin 75 mg BID
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dorzagliatin 75 mg QD
Number of subjects: 24
Study: 26984807

Group type: EXPERIMENTAL
Intervention: Topiramate administered once a night at a dose of 2 mg/kg/day
Number of subjects: 85

Group type: COMPARATOR
Intervention: Topiramate administered twice a day at a dose of 4 mg/kg/day
Number of subjects: 85
Study: 25280957

Group type: EXPERIMENTAL
Intervention: Liraglutide plus calorie-restricted diet
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo plus calorie-restricted diet
Number of subjects: 50
Study: 22994021

Group type: EXPERIMENTAL
Intervention: Nifedipine and bed rest
Number of subjects: 188
Study: 20103825

Group type: EXPERIMENTAL
Intervention: High-quality RCTs
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Intermediate-quality RCTs
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Low-quality RCTs
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: High-quality RCTs supporting claims
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: High-quality RCTs not sponsored by pharmaceutical companies
Number of subjects: 250
Study: 17578905

Group type: EXPERIMENTAL
Intervention: Remifentanil and midazolam sedation
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Remifentanil pharmacokinetics
Number of subjects: 26
Study: 15760531

Group type: EXPERIMENTAL
Intervention: CABG with cardiopulmonary bypass (CCABG)
Number of subjects: 60

Group type: COMPARATOR
Intervention: CABG without cardiopulmonary bypass (OPCABG)
Number of subjects: 60
Study: 12029630

Group type: EXPERIMENTAL
Intervention: 7.5 mg losartan
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (no losartan)
Number of subjects: 19
Study: 10220630

Group type: EXPERIMENTAL
Intervention: Intravenous metoprolol 5 mg x 3 plus 5 mg morphine
Number of subjects: 262

Group type: COMPARATOR
Intervention: Intravenous placebo plus 5 mg morphine
Number of subjects: 262
Study: 7778826

Group type: COMPARATOR
Intervention: Azathioprine or 6-mercaptopurine therapy
Number of subjects: 9

Group type: COMPARATOR
Intervention: Azathioprine therapy
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Continuation of therapy for at least 17 weeks
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Higher dose of azathioprine
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Increased cumulative dose
Number of subjects: 9
Study: 1401645

Group type: EXPERIMENTAL
Intervention: Solenopsis invicta (Sol i) fire ant venom (IFAV)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Imported fire ant whole body extracts (IFA WBEs)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Radioallergosorbent test (RAST) to IFAV and both IFA WBEs
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Skin testing with IFAV
Number of subjects: 66

Group type: COMPARATOR
Intervention: Skin testing with IFA WBE
Number of subjects: 66
Study: 6496202

Group type: EXPERIMENTAL
Intervention: Nicotine-containing cigarette
Number of subjects: 10

Group type: COMPARATOR
Intervention: Zero-nicotine cigarette
Number of subjects: 10
Study: 31862032

Group type: EXPERIMENTAL
Intervention: Simulated driving in a conversation robot's presence
Number of subjects: 126

Group type: COMPARATOR
Intervention: Simulated driving alone
Number of subjects: 126
Study: 28978975

Group type: EXPERIMENTAL
Intervention: 1-year tailored multi-component physical activity intervention program
Number of subjects: 9858

Group type: COMPARATOR
Intervention: Routine health education (Control)
Number of subjects: 9858
Study: 27711088

Group type: EXPERIMENTAL
Intervention: Combination of tryptophan, Satureja montana, Tribulus terrestris, Phyllanthus emblica extracts (1 tablet per day for 3 months)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of tryptophan, Satureja montana, Tribulus terrestris, Phyllanthus emblica extracts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Counseling and sexual behavioral treatment (Control Group B)
Number of subjects: 0
Study: 24890456

Group type: EXPERIMENTAL
Intervention: Looking during needle insertion
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Looking away during needle insertion
Number of subjects: 192

Group type: COMPARATOR
Intervention: Sharp scratch verbal cue
Number of subjects: 192

Group type: COMPARATOR
Intervention: Ready? verbal cue
Number of subjects: 192
Study: 24160714

Group type: EXPERIMENTAL
Intervention: CLiAC program (intervention)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 24
Study: 19931950

Group type: EXPERIMENTAL
Intervention: Web-based learning unit
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional lecture
Number of subjects: 0
Study: 18172652

Group type: EXPERIMENTAL
Intervention: Postmenopausal osteoporotic women
Number of subjects: 70

Group type: COMPARATOR
Intervention: Healthy young women
Number of subjects: 70
Study: 16242246

Group type: EXPERIMENTAL
Intervention: Action plans
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Intention
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Gender differences
Number of subjects: 223
Study: 12519412

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg daily
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 10735260

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 8709603

Group type: EXPERIMENTAL
Intervention: Ru He Chong Ji
Number of subjects: 280
Study: 2719349

Group type: EXPERIMENTAL
Intervention: Sulfite
Number of subjects: 1

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study: 363229

Group type: EXPERIMENTAL
Intervention: Azathioprine plus prednisone (2.5 mg/kg body weight daily)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Prednisone alone
Number of subjects: 25
Study: 31539169

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) - 6 weekly 2-hour group sessions
Number of subjects: 91

Group type: COMPARATOR
Intervention: Survivorship Education (SE) - 6 weekly 2-hour group sessions
Number of subjects: 91

Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC) - one 30-minute group coaching session with survivorship readings
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 91
Study: 28682439

Group type: EXPERIMENTAL
Intervention: Continuous epidural anesthesia
Number of subjects: 92

Group type: COMPARATOR
Intervention: Local anesthesia
Number of subjects: 92
Study: 25091596

Group type: EXPERIMENTAL
Intervention: Dialysate potassium concentration between 1.6 and 2.5 mEq/L
Number of subjects: 551

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 551
Study: 23797557

Group type: EXPERIMENTAL
Intervention: Disinfection with alcohol 70% (w/v) without previous cleaning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Disinfection with alcohol 70% (w/v) preceded by cleaning
Number of subjects: 0
Study: 21197586

Group type: EXPERIMENTAL
Intervention: palm olein
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: olive oil
Number of subjects: 10

Group type: COMPARATOR
Intervention: lard
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: high fat load (50 g fat)
Number of subjects: 10
Study: 18070658

Group type: EXPERIMENTAL
Intervention: Low-glycemic index diet
Number of subjects: 40

Group type: COMPARATOR
Intervention: ADA diet
Number of subjects: 40
Study: 16544256

Group type: EXPERIMENTAL
Intervention: SP plus AS
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: SP plus AQ
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: AL (Coartem)
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: ACT (Artemisinin-based combination therapy)
Number of subjects: 528
Study: 14693168

Group type: EXPERIMENTAL
Intervention: Post-thrombotic syndrome assessment using a standardized score
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Subjective symptom assessment
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Objective symptom assessment
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Risk factor analysis for PTS development
Number of subjects: 153
Study: 10902643

Group type: EXPERIMENTAL
Intervention: Combination antiretroviral therapy (HAART)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monitoring CD4-cell counts and viral load
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Starting HAART when CD4-cell count drops below 350 cells/microL
Number of subjects: 0
Study: 8884421

Group type: EXPERIMENTAL
Intervention: Slideboard exercise (3 days per week, 1 hour each session, over a 10 week period)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (11 females)
Number of subjects: 25
Study: 8317753

Group type: EXPERIMENTAL
Intervention: General anesthesia using isolated forearm technique with intravenous thiopental (3 mg/kg, 250 mg maximum) and succinylcholine (1.5 mg/kg), followed by a mixture of 50% N2O, 50% O2, and 0.5% halothane at a flow of 5 L/min and end‐tidal CO2 at 40 mm Hg. Paralysis maintained with a 0.1% succinylcholine infusion.
Number of subjects: 30
Study: 2427405

Group type: EXPERIMENTAL
Intervention: Anabolic steroids plus phenformin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 29954701

Group type: EXPERIMENTAL
Intervention: 1 mA tDCS
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 2 mA tDCS
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 40
Study: 27134058

Group type: EXPERIMENTAL
Intervention: Coronary Computed Tomography Angiography (CTA)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional Invasive Coronary Angiography (ICA)
Number of subjects: 71
Study: 25035351

Group type: EXPERIMENTAL
Intervention: Chamber X
Number of subjects: 0

Group type: COMPARATOR
Intervention: IQ and Finn chambers
Number of subjects: 0
Study: 23301437

Group type: EXPERIMENTAL
Intervention: Talking About Live Kidney Donation (TALK) social worker intervention (SWI)
Number of subjects: 0
Study: 20209200

Group type: EXPERIMENTAL
Intervention: One implant in the symphyseal area
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Two implants in the canine positions
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 36
Study: 18665190

Group type: EXPERIMENTAL
Intervention: ACE (doxorubicin 50 mg/m(2) i.v., cyclophosphamide 1 g/m(2) i.v., etoposide 120 mg/m(2) i.v. on day 1, etoposide 240 mg/m(2) orally for 2 days)
Number of subjects: 280

Group type: COMPARATOR
Intervention: PE (cisplatin 80 mg/m(2) and etoposide 120 mg/m(2) i.v. on day 1, etoposide 240 mg/m(2) orally for 2 days)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: ACE
Number of subjects: 280

Group type: COMPARATOR
Intervention: PE
Number of subjects: 280
Study: 15875295

Group type: EXPERIMENTAL
Intervention: Pudendal nerve block with 0.5 percent bupivacaine (n = 81)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Spinal anesthesia with 0.5 percent bupivacaine (n = 82)
Number of subjects: 163
Study: 12885712

Group type: EXPERIMENTAL
Intervention: Casein-hydrolysate formula (CH-1 or CH-2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Casein-hydrolysate formula (CH-2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydrolysate formulas (CH-1 or CH-2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Casein-hydrolysate formulas (CH-1 or CH-2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Whey-hydrolysate formula (WH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Breastfed infants
Number of subjects: 0
Study: 10479004

Group type: EXPERIMENTAL
Intervention: Twin-shot SWL technique (Group 1; N = 30)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Single-shot SWL technique (Group 2; N = 29)
Number of subjects: 59
Study: 8693524

Group type: EXPERIMENTAL
Intervention: Late reflush with organ preservation fluid
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no late reflush)
Number of subjects: 18
Study: 1744910

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hormone treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Relaxation instructions
Number of subjects: 0
Study: 6190545

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX), 40 mg escalated to 60 mg/m2 IV push weekly
Number of subjects: 44

Group type: COMPARATOR
Intervention: Cisplatin (DDP), 50 mg/m2 6 hour infusion days 1 and 8 every 4 weeks
Number of subjects: 44
Study: 30624856

Group type: EXPERIMENTAL
Intervention: Rolapitant tablet (2 × 90-mg tablets)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Rolapitant capsule (4 × 45-mg capsules)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Both formulations (tablet and capsule)
Number of subjects: 87
Study: 29878040

Group type: EXPERIMENTAL
Intervention: nab-Paclitaxel plus carboplatin (nab-P/C)
Number of subjects: 191

Group type: COMPARATOR
Intervention: nab-Paclitaxel plus gemcitabine (nab-P/G)
Number of subjects: 191

Group type: COMPARATOR
Intervention: gemcitabine plus carboplatin (G/C)
Number of subjects: 191
Study: 26951105

Group type: EXPERIMENTAL
Intervention: Algorithm-guided goal-directed haemodynamic therapy (GDT)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Good standard clinical care (control)
Number of subjects: 180
Study: 25123098

Group type: EXPERIMENTAL
Intervention: Continuing medical education for GPs (≥ 40 hours) in palliative care (PG)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard care without continuing education (CG)
Number of subjects: 68
Study: 21813060

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19463468

Group type: EXPERIMENTAL
Intervention: Polymer-coated rapamycin-eluting stents
Number of subjects: 24

Group type: COMPARATOR
Intervention: Nonpolymer rapamycin-eluting stents
Number of subjects: 24
Study: 17214679

Group type: EXPERIMENTAL
Intervention: Dry-type iontophoretic device
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (untreated palm)
Number of subjects: 10
Study: 15500594

Group type: EXPERIMENTAL
Intervention: e‐SBI (web-based assessment and personalized feedback)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Leaflet-only control group
Number of subjects: 104
Study: 11340333

Group type: EXPERIMENTAL
Intervention: CD4+IL13+ lymphocytes from cord blood mononuclear cells (CBMC) derived from atopic mothers
Number of subjects: 208

Group type: COMPARATOR
Intervention: Cord blood cytokine production (IFN-gamma, IL-4, IL-5)
Number of subjects: 208
Study: 9740526

Group type: EXPERIMENTAL
Intervention: Medscand Endorette
Number of subjects: 152

Group type: COMPARATOR
Intervention: Pipelle de Cornier
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 152